Page last updated: 2024-10-30

leflunomide and Neuroendocrine Tumors

leflunomide has been researched along with Neuroendocrine Tumors in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tatar, G1
Beyhan, E1
Arslan, E1
Ergül, N1
Çermik, TF1

Other Studies

1 other study available for leflunomide and Neuroendocrine Tumors

ArticleYear
Effect of Leflunomide Use on 68Ga-DOTATATE Biodistribution in a Case With Neuroendocrine Tumor.
    Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2

    Topics: Humans; Leflunomide; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Em

2023